ikeGPS H1 FY27 slides: subscription revenue up 22%, ARR growth expected

Rapport Therapeutics director Paul M. buys $974k in shares

Investing.com · News 14m ago

Rapport Therapeutics director John Maraganore acquires $248,891 in stock

Investing.com · News 15m ago

Japanese Bond Yields Fall as AI Jitters Spur Haven Demand

Bloomberg · Markets 18m ago

Microsoft develops AI tool that can diagnose ’sequentially’ like a doctor

Investing.com · News 18m ago

Oil prices cool from 5-month highs as Trump invokes defense production act

Investing.com · News 19m ago

Earnings call transcript: ikeGPS Group flags stronger second half in Q2 2026

Investing.com · News 21m ago

Japan manufacturing growth slows to 7-month low in October, PMI shows

Investing.com · News 23m ago

Why Is BigBear.ai Stock Crashing, and is it a Buying Opportunity?

NASDAQ · Markets 24m ago

Taiwan Bourse May Take Further Damage On Friday

NASDAQ · Markets 27m ago

Innsuites Hospitality Trust CEO sells $2.01 billion in shares

Investing.com · News 30m ago